We are live on ! Find out more
DERM

Dermira, Inc.
DERM

Delisted

DERM was delisted on the 19th of February, 2020.

133 hedge funds and large institutions have $776M invested in Dermira, Inc. in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 47 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

162% more call options, than puts

Call options by funds: $14.9M | Put options by funds: $5.67M

139% more capital invested

Capital invested by funds: $325M → $776M (+$451M)

15% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 26

2% more funds holding

Funds holding: 131133 (+2)

11% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 47

Holders
133
Holders Change
+2
Holders Change %
+1.53%
% of All Funds
2.62%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
30
Increased
42
Reduced
47
Closed
26
Calls
$14.9M
Puts
$5.67M
Net Calls
+$9.2M
Net Calls Change
+$9.32M

DERM Hedge Fund Activity: Q4 2019 in Review

133 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q4 2019, worth a combined $776M — up 139% from $325M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new DERM positions and 26 closed out — a net gain of 4 holders — while 42 added to existing stakes and 47 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $16.9M. The largest seller was PFM Health Sciences, cutting an estimated $13.5M.

  • 133 institutional investors held Dermira, Inc. (DERM) as of Q4 2019, up from 131 in Q3 2019.
  • Funds reported $776M of Dermira, Inc. stock for Q4 2019, up 139% quarter-over-quarter.
  • 30 funds opened new Dermira, Inc. positions in Q4 2019 and 26 closed out, a net change of +4 holders.
  • The largest Dermira, Inc. buyer in Q4 2019 was Fidelity Investments, an estimated $16.9M added.
  • The largest Dermira, Inc. seller in Q4 2019 was PFM Health Sciences, an estimated $13.5M sold.

Based on aggregated 13F filings for Q4 2019.